Skip to main content
logo
Curiox Biosystems Co., Ltd (KOSDAQ:445680)
South Korea flag South Korea · Delayed Price · Currency is KRW
48,400
-950 (-1.93%)
At close: Sep 3, 2026

Curiox Biosystems Financials Overview

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
5,7355,1524,5886,7887,2375,523
Revenue Growth
49.92%12.29%-32.41%-6.21%31.04%25.97%
Gross Profit
2,8132,1352,5593,8254,7333,494
Operating Income
-13,042-12,314-13,378-10,557-11,421-8,337
Net Income
-12,780-27,177-8,089-10,040-11,495-14,524
Earnings Per Share
-750.60-1645.17-503.00-702.41-1619.76-1114.50
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
10,50117,78528,18817,9098,72219,819
Total Debt
517.582,4508,142965.16387.2130,446
Net Cash (Debt)
9,98415,33520,04516,9448,334-10,627
Net Cash Growth
-26.05%-23.50%18.30%103.30%--
Net Cash Per Share
586.38928.331246.491185.371174.42-815.46

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-9,271-11,109-9,698-8,164-9,888-5,126
Capital Expenditures
-78.82-136.1-257.88-211.53-822.86-261.26
Free Cash Flow
-9,350-11,245-9,956-8,376-10,711-5,387
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
49.05%41.45%55.77%56.35%65.40%63.27%
Operating Margin
-227.43%-239.04%-291.61%-155.53%-157.81%-150.95%
Pretax Margin
-223.49%-530.56%-174.29%-150.43%-156.01%-266.04%
Profit Margin
-222.85%-527.55%-176.32%-147.92%-158.83%-262.98%
FCF Margin
-163.04%-218.29%-217.02%-123.39%-148.00%-97.54%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
142.95388.8265.2359.45--